Dear Michael
I am contacting you because I saw on BioStar that you have a very deep knowledge in the field of RNA-seq.
Note that I am a novice in bioinformatics. My situation: I have raw counts for the tumor I am interested in (however no non-tumor control). However, I would like to control the expression with non-tumour tissue (muscle tissue). To do this, I would like to take the raw counts from GTEx, merge them with the raw counts from my tumour, apply CombatSeq to minimise the batch effect, then use DESeq2 and GSEA to see the differences in expression. Does this make sense to you? Is this method correct? I have bulk RNA seq data.
Thanks in advance and best regards
•
written
by
s.haefliger •
1 answer
If you completely confound condition and technical batch effect (in your case, tumor = batch 1 and control = batch2), there's no way to distinguish the technical effect from the biological effect of interest. I.e. if you apply CombatSeq to remove the batch effect, you will also remove all biologically meaningful differences between tumor and control.
Log in to answer this question.
-
RNA-seq, three comparisons - stick to one linear model, or use separate models?
written by noodlejackson •
-
analyze gene expression of 3 genes in RNA-Seq data
written by pinheirofabiano •
-
WGCNA on TCGA case-control
written by Maliha •
-
GTEX RNA Seq. Pipeline
written by Nona •
-
Any database with RNA-Seq signal files for GTEx data?
written by thejustpark
-
the selection between legacy archive and harmonization in TCGA when compared to GTEx in the differe…
written by Yun
-
Expression values for normal tissues
written by rizoic
-
Can remote, but same type, tissue be used as RNA-Seq normal control for tumor study?
written by CY
-
Processing GTEx RNA-Seq data using the TCGA bioinformatic pipeline
written by smsinks •
-
RNA-Seq and WGS analysis applied in genes expression
written by misterie
